Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 18, 2022

Second-Line Treatment After Docetaxel, Cisplatin, and 5-Fluorouracil in Metastatic SCC of the Anus

European Journal of Cancer


Additional Info

European Journal of Cancer
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies
Eur. J. Cancer 2022 Feb 01;162(xx)138-147, M Stouvenot, A Meurisse, A Saint, B Buecher, T André, E Samalin, M Jary, F El Hajbi, N Baba-Hamed, S Pernot, MC Kaminsky, O Bouché, J Desrame, M Zoubir, D Smith, F Ghiringhelli, A Parzy, C de la Fouchardiere, H Almotlak, A Vienot, M Jacquin, J Taieb, T Nguyen, D Vernerey, C Borg, S Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading